Clinical Trial Update: Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of ilaprazole at 5, 20 and 40 mg daily and lansoprazole 30 mg daily for healing erosive esophagitis; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• Ilaprazole (ilaprazole)
• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Takeda | Conditions: Esophagitis | Phase 2 | Status: COMPLETED